Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4580-4589, Vol. 69, No. 7
Biotechnology Laboratory and Departments of
Microbiology and Immunology, Biochemistry and Molecular
Biology1 and Department of Pathology and
Laboratory Medicine,3 University of British
Columbia, and Diabetes Research Laboratory, School of
Kinesiology, Simon Fraser University,4
Vancouver, British Columbia, Canada, and Institute of
Bacteriology, Mycology and Hygiene, University of Veterinary Medicine,
Vienna, Austria2
Received 17 April 2001/Accepted 24 April 2001
Significant changes occur in intestinal epithelial cells after
infection with enteropathogenic Escherichia coli (EPEC).
However, it is unclear whether this pathogen alters rates of apoptosis. By using a naturally occurring weaned rabbit infection model, we
determined physiological levels of apoptosis in rabbit ileum and ileal
Peyer's patches (PP) and compared them to those found after infection
with adherent rabbit EPEC (REPEC O103). Various REPEC O103 strains were
first tested in vitro for characteristic virulence features. Rabbits
were then inoculated with the REPEC O103 strains that infected cultured
cells the most efficiently. After experimental infection, intestinal
samples were examined by light and electron microscopy. Simultaneously,
ileal apoptosis was assessed by using terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
(TUNEL) and caspase 3 assays and by apoptotic cell counts based on
morphology (hematoxylin-and-eosin staining). The highest physiological
apoptotic indices were measured in PP germinal centers (median = 14.7%), followed by PP domed villi (8.1%), tips of absorptive villi
(3.8%), and ileal crypt regions (0.5%). Severe infection with REPEC
O103 resulted in a significant decrease in apoptosis in PP germinal
centers (determined by TUNEL assay; P = 0.01), in
the tips of ileal absorptive villi (determined by H&E staining;
P = 0.04), and in whole ileal cell lysates
(determined by caspase 3 assay; P = 0.001). We
concluded that REPEC O103 does not promote apoptosis. Furthermore, we
cannot rule out the possibility that REPEC O103, in fact, decreases
apoptotic levels in the rabbit ileum.
Enteropathogenic Escherichia
coli (EPEC) is the leading cause of bacterium-mediated infantile
diarrhea, killing several hundred thousand children every year
(19, 30). Natural animal disease models such as rabbits
infected with rabbit EPEC serogroup O103 (REPEC O103) have been used to
study pathogenesis. Apart from its chromosome-encoded adhesive factor
(AF/R2) that triggers initial diffuse adherence to intestinal
epithelial cells, REPEC O103 possesses the same virulence factors and
mechanisms as human EPEC. It secretes several effector proteins via a
type III secretion system (EspA, EspB, EspD, and Tir), it produces the
outer membrane protein intimin, and it is a Shiga toxin-negative strain
(1, 28, 32). Binding between intimin and its translocated
receptor, Tir, results in the formation of attaching-and-effacing
lesions characterized by intimate attachment between the bacterium and
the host epithelial cell with effacement of microvilli resulting with
the pathogen residing upon actin-rich pedestals (9, 21).
Despite significant research, the pathogenic mechanisms by which EPEC
causes diarrheal disease remain undefined. Specific host responses
could include apoptotic changes in macrophages and/or intestinal
epithelial cells, as have been reported for a variety of pathogens in
vitro. However, to date, neither histopathologic reports nor in vivo investigations have described changes in apoptotic activities due to
EPEC infection (10, 38).
Invasive and/or toxin-producing enteropathogens such as
Salmonella, Shigella, and Yersinia
species, enterohemorrhagic E. coli (EHEC), and
Helicobacter pylori increase apoptosis in macrophages and/or
epithelial cells in vivo (18, 20, 23, 27, 29, 34, 42, 45,
46). Similarly, Listeria and enteroinvasive E. coli increase apoptosis in vitro (22, 45). Cell lines
such as T84 and HeLa cells infected with EPEC also show features of apoptosis (6). However, the cell permeability to vital
dyes such as trypan blue and propidium iodide that was observed is not
a definitive feature of apoptosis (late apoptotic cells are propidium
iodide positive), and dye-positive cells were not consistently seen beneath adherent bacteria. In addition, infected cells rarely showed distinct morphologic characteristics of apoptosis, including DNA
breakdown, and the increase in apoptotic signals was, in general, much
weaker than that caused by invasive or toxin-producing pathogens. Other
investigators found that EPEC, REPEC serogroup O15 (RDEC-1), and
Citrobacter rodentium directly inhibit the production of
interleukin-2 (IL-2), IL-4, and gamma interferon, suggesting that these
pathogens do not increase apoptosis (26). In addition,
researchers have speculated that EPEC adherence potentially stimulates
some antiapoptotic pathways within the host cell due to activation of
protein kinase C, tyrosine kinases, and the nuclear transcription
factor NF- Based on these conflicting reports, we set out to determine the
influence of EPEC infection on apoptotic intestinal activities in vivo
by using the naturally infected, weaned rabbit model. Several REPEC
O103 strains isolated in different countries were first tested in vitro
for Esp and Tir protein secretion, plasmid profile, and adherence.
Animals were then inoculated with strains expressing characteristic
representative virulence traits. We evaluated the incidence of
apoptosis in sections from the ileum and ileal Peyer's patches (PP),
sites that REPEC colonizes (14). The methods used included
terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end
labeling (TUNEL) and caspase 3 assays and counting of apoptotic cells
based on their characteristic morphology in sections stained with
hematoxylin and eosin (H&E). We found that apoptotic activities in the
rabbit ileum and ileal PP were significantly decreased when REPEC O103
disease was fully established.
Bacterial strains and culture conditions.
Various REPEC O103
strains isolated from weaned rabbits with heavy diarrhea were kindly
provided by Jorge Blanco (Laboratorio de Referencia de E. coli, Lugo, Spain), Johan E. Peeters (National Institute of
Veterinary Research, Brussels, Belgium), and Michael Davis
(Gastro-Enteric Disease Laboratory, University Park, Pa.). Detailed strain characteristics are listed in Table
1. Bacterial strains were grown in
Luria-Bertani broth at 37°C overnight without shaking prior to
infection. To evaluate antibiotic resistance, strains were tested on
Luria-Bertani broth plates containing 12 different antibiotics. To
select the most appropriate REPEC O103 strains for rabbit infection,
strains were screened for characteristic features, including the
profile of type III secreted effector proteins, plasmid profile, HeLa
cell adherence characteristics, and Shiga toxin production (1,
25, 32, 37).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4580-4589.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Decreased Apoptosis in the Ileum and Ileal Peyer's
Patches: a Feature after Infection with Rabbit Enteropathogenic
Escherichia coli O103
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
B, leading to the expression of IL-8 (7, 36,
39).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial strains used in this study
Profile of type III secreted effector proteins. Bacterial overnight cultures were diluted 1:100 in Dulbecco modified Eagle medium and incubated for 6 h at 37°C in a 5% CO2 atmosphere. After removal of bacteria by centrifugation, the supernatant was precipitated with 10% ice-cold trichloroacetic acid and kept on ice for 1 h. After centrifugation, the pellets were resuspended in Laemmli sample buffer and analyzed by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis (24). Production of Tir and EspA to -D was then characterized.
Plasmid profile. Bacterial overnight cultures were centrifuged, and the pellet was resuspended in TAE (40 mM Tris-acetate, 2 mM EDTA, pH 7.4) and lysis solution (3% sodium dodecyl sulfate, 50 mM Tris-base, 2 N NaOH) and kept at 55°C for 30 min. After repeated phenol extraction and ethanol precipitation, pellets were analyzed on a 1% agarose gel.
Adherence and immunofluorescence on HeLa cells. HeLa cells (104) were inoculated on coverslips and grown overnight in Dulbecco modified Eagle medium containing 10% (vol/vol) fetal calf serum at 37°C in a 5% CO2 atmosphere. At 70% confluent growth, cells were infected for 5 h with bacterial overnight cultures of REPEC O103 strains and for 3 h with wild-type EPEC and the EPEC cfm mutant strain. Cells were washed with phosphate-buffered saline (PBS) and then fixed with 2.5% paraformaldehyde in PBS (pH 7.4) for 10 min at 37°C. After five wash in PBS, cells were permeabilized with 0.2% saponin in PBS in the presence of antiphosphotyrosine antibodies, clone 4G10 (Upstate Biotechnology, Lake Placid, N.Y.). Alexa 594-conjugated goat anti-mouse immunoglobulins G and M (Molecular Probes, Eugene, Oreg.) were used as secondary antibodies to visualize tyrosine-phosphorylated proteins beneath adherent bacteria. To stain filamentous actin, cells were incubated with Alexa 488-conjugated phalloidin (Molecular Probes). Adherence of REPEC O103 strains and immunostaining of the samples were visualized and analyzed by using a Zeiss Axioskop microscope.
Shiga toxin. A Shiga-toxin-producing E. coli strain, serotype O103:H2, was isolated from a 6-year-old girl with hemolytic-uremic syndrome after a urinary tract infection (40). To confirm the absence of Shiga toxin in REPEC O103 strains with the same serotype, bacteria were tested by using the Premier EHEC test kit (Meridian Diagnostics, Inc., Cincinnati, Ohio) in accordance with the manufacturer's instructions. In addition to the positive and negative controls provided with the test kit, EHEC strains 86-24 and 87-23 (kindly provided by Phillip Tarr) were used as positive and negative controls, respectively.
Rabbit infection and experimental design. Weaned New Zealand White rabbits (female, 532 to 890 g, 28 to 33 days old) were obtained from Joe Bet Rabbits Limited (Abbottsford, British Columbia, Canada). Before infection, fecal suspensions were spread on MacConkey plates to ensure the absence of REPEC O103. All rabbit stools were confirmed to be free of the pathogen by slide agglutination with O103 antiserum (Gastro-Enteric Disease Laboratory). In addition, fecal suspensions were spread on MacConkey plates to screen for the presence of indigenous members of the family Enterobacteriaceae. Enterobacteriaceae were tested for antibiotic resistances, and rabbits were infected with REPEC O103 strains with different antibiotic resistances. For infection, rabbits were anesthetized and inoculated via an orogastric tube with 2 ml of overnight cultures (108 bacteria per rabbit) of REPEC O103 strains B6/RD10a (n = 6), B14/RD55a (n = 4), B20/RD32a (n = 3), and 85/150Nal+ (n = 3). Control rabbits (n = 3) received only PBS. Animals were watered and fed ad libitum before and after infection. Weight gain, symptoms of diarrhea, and fecal bacterial shedding of the inoculated strains were monitored daily. For specific identification of the test strains, fecal suspensions were spread on MacConkey plates containing specific antibiotics. Animals were sacrificed when diarrhea occurred or up to 14 days after infection. Tissue samples from the ileum and ileal PP were excised immediately after sacrifice by intravenous injection of ketamine and an overdose of sodium pentobarbital in accordance with the guidelines of the Canadian Council of Animal Care and the University of British Columbia. Samples were washed three times in PBS before further processing for histological and immunohistochemical, scanning electron microscopic (SEM), and enzymatic studies.
Tissue preparation for light microscopy, including H&E and TUNEL staining. Tissues were fixed in 10% neutral buffered formalin and processed for paraffin embedding. Serial 4-µm-thick sections were cut onto glass slides and stained with H&E and Gram stain. To screen for and ensure the absence of segmented filamentous bacteria that are known to inhibit REPEC O103 infections, sections were stained with carbonin-thionin (15). Apoptosis-related DNA fragmentation was determined by the TUNEL assay using the ApopTag Peroxidase In Situ Apoptosis Detection Kit (Intergen Company). Slides were first incubated overnight at 60°C to increase the adherence of sections. Samples were then processed by following the manufacturer's instructions. For color development, 3,3'-diaminobenzidine tetrahydrochloride (Sigma Chemical Co., St. Louis, Mo.) was applied to the tissue sections. Specimens were counterstained with carmalum for morphologic definition, dehydrated in a series of ethanols and xylene, and mounted under a glass coverslip. Specimens were examined and photographed with an Olympus AH-2 light microscope. Pictures were captured with the Metaview imaging software. On TUNEL- or H&E-stained sections, apoptotic cells were enumerated by counting 100 cells in randomly selected fields of a total of 10 (i) tips of ileal absorptive villi, (ii) ileal crypts, (iii) tips of absorptive villi of PP, (iv) domed villi of PP, and (v) germinal centers of PP. Counting was done blindly. In all, 1,000 cells were enumerated at each intestinal site and the apoptotic index was expressed as the percentage of apoptotic cells per 100 cells enumerated.
Tissue preparation for SEM. Tissues were prefixed in 2.5% glutaraldehyde, rinsed in 0.1 M cacodylate buffer, and postfixed in 1% osmium tetroxide. After dehydration in a series of graded ethanols, specimens were critical point dried, coated with gold, and examined with a Leica 250 MK III scanning electron microscope.
Tissue preparation for the caspase 3 assay. Tissues were kept in liquid nitrogen until processing. Caspases (cysteinyl aspartate-specific proteinases) are believed to be among the primary effector molecules of apoptosis. Once activated, caspases are responsible for cleaving various proteins, thereby disabling important cellular structural, functional, and repair processes. In the present experiments, caspase 3/7-like proteolytic activities were assessed in rabbit ileum and ileal PP. To evaluate caspase 3 activity, cell lysates were prepared by homogenization of tissue in cold cell lysis buffer (20 mM Tris [pH 8], 137 mM NaCl, 10% glycerol, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, aprotinin at 10 µg/ml). Assays were performed with 96-well microtiter plates by incubating 25 µl of cell lysate in 125 µl of reaction buffer (1% NP-40, 20 mM Tris-HCl [pH 7.5], 137 mM NaCl, 10% glycerol) containing the caspase 3 substrate acetyl-Asp-Glu-Val-Asp-amino-4-methylcoumarin (Ac-DEVD-AMC; Calbiochem, Cambridge, Mass.) at 100 µM. Lysates were incubated at 37°C for 2 h, and fluorescence levels were determined with a CytoFluor2350 (PerSeptive Biosystems, Burlington, Ontario, Canada) set at excitation and emission wavelengths of 380 and 460 nm, respectively.
Statistical analysis. To compare apoptotic activities between controls (group 0) and diseased rabbits (groups 1 to 3), the unpaired Student t test was applied. The test was repeated by the nonparametric Mann-Whitney U test where Gaussian distribution was not assumed. Values represent the median along with the minimum and maximum values. Statistical significance was defined as P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Profile of proteins secreted by REPEC O103 strains. We have previously shown that REPEC O103 strain 85/150Nal+ secretes EspA, EspB, and EspD into its culture medium (1). Likewise, strains B6/RD10a, B6/RD21a, B14/RD55a, B20/RD32a, ECRC 88-0990, 85/150, and 85/150Nal+ secreted EspA, EspB, EspD, and Tir into their culture media (data not shown). In the remaining strains, these proteins were difficult to detect by Coomassie blue staining after polyacrylamide gel electrophoresis. Since it is likely that the reduced amount or absence of these secreted proteins could decrease virulence, we did not use these strains for rabbit infections.
Plasmid profile of REPEC O103 strains. It has been shown that the initial adherence of REPEC O103 is due to a chromosomally encoded adhesin, AF/R2 (adhesive factor/rabbit 2) (28, 33). The initial adherence of EPEC and another REPEC strain (RDEC-1), however, is mediated by the plasmid-encoded bundle-forming pilus and AF/R1 (adherence factor/rabbit 1), respectively (5, 11). We found that, except for ECRC O1 and ECRC O103, all strains harbor two to five plasmids of various sizes (data not shown). The plasmid profiles of Spanish strains B6/RD10a, B14/RD55a, and B20/RD32a and Belgian strain 85/150Nal+, which were used for the in vivo infection study, were only partially identical. While rabbits infected with the Spanish strains experienced heavy diarrhea (see below), rabbits infected with the Belgian strain showed only moderate disease symptoms. As the profiles of the Spanish strains also differed in size, our observations indicate that there is no specific conserved plasmid that is required for REPEC O103 virulence.
Adherence to HeLa cells and pedestal formation.
We have
previously shown that bacterial adherence, actin accumulation, and
tyrosine-phosphorylation of host cell proteins in vitro are essential
for REPEC O103 virulence in vivo (1). As shown in Table
2, the REPEC O103 strains tested in this
study adhered to HeLa cells (except for ECRC O103) in low (+), moderate (++), high (+++), or very high (++++) numbers in a diffuse way, whereas
EPEC strains formed microcolonies showing localized adherence. In
most cases, cytoskeletal actin accumulated beneath attached bacteria,
resulting in pedestal formation. Additionally, host cell proteins
were tyrosine phosphorylated at attachment sites, resulting in distinct
horseshoe-shaped structures.
|
Shiga toxin is not present in REPEC O103 strains. As expected, all of the REPEC O103 strains tested in the present study did not produce detectable toxins (Table 1). In contrast, control strain EHEC 86-24, secreting Shiga toxin II, showed a positive result.
Virulence of REPEC O103 strains in rabbits. Based on the in vitro characteristics described above, Spanish REPEC O103 strains B6/RD10a, B14/RD55a, and B20/RD32a and Belgian strain 85/150Nal+ were chosen for further infection studies. Rabbits inoculated with strains B6/RD10a (n = 6), B14/RD55a (n = 4), and B20/RD32a (n = 3) showed weight loss and experienced moderate to heavy diarrhea (4 of 6, 1 of 4, and 2 of 3, respectively), which began between 2 and 7 days after infection. Fecal concentrations of the pathogen reached 4 × 1011 CFU/g of stool. Rabbits infected with the Belgian strain (n = 3) experienced weight loss (2 of 3). Stools were soft and harbored up to 5 × 109 CFU/g. When indigenous Enterobacteriaceae were detected in rabbit stools before experimental infection (5 of 16), lack of weight gain was insignificant and no change in stool consistency was observed. These findings support the hypothesis that indigenous bacteria may inhibit bacterial infections in a competitive way (2, 35).
Light and SEM observations of REPEC O103-infected ileum and ileal
PP.
Consistent with previous reports, intestinal epithelial
changes were prominent (1, 14). SEM observations (Fig.
1) illustrate that villi were blunted,
stunted, and fused together (Fig. 1A; see also Fig. 2G and H). Bacteria
intimately attached to ileal absorptive villi, heavily covering wide
parts of their surfaces in a diffuse pattern (Fig. 1B; see also Fig.
2G). After bacterial detachment, honeycomb-like structures were visible
(Fig. 1C). Compared to uninfected tissue (Fig.
2A and B), crypt
regions from infected rabbits were enlarged and goblet cells were
increased in number (Fig. 3A). Luminal
mucus covered wide parts of the ileum, and
macrophages were found assembled above the epithelium. H&E staining
showed distinct immigration of polymorphonuclear leukocytes, lymphocytes, plasma cells, and sometimes erythrocytes into the mucosal
epithelium of absorptive villi, reflecting increased tissue inflammation (Fig. 2H). The height and width of PP domed villi were
diminished during the later stages of infection, when disease symptoms
were severe. In contrast, absorptive villi decreased in height but grew
in width due to the influx of inflammatory cells. Segmented filamentous
bacteria (15) were not detected in any of the rabbit
tissues by either SEM or carbonin-thionin staining.
|
|
|
Apoptosis
a physiological feature of the rabbit ileum.
Tissue
samples from uninfected control rabbits (n = 3) and
from rabbits that did not show disease symptoms despite experimental infection (n = 5) were examined for the presence of
apoptotic cells in the ileum and ileal PP after TUNEL or H&E staining
and by the caspase 3 assay. Cells with dark brown nuclei were
considered TUNEL positive (Fig. 2C to E). For H&E counts, cells were
identified as apoptotic on the basis of their morphology by using
previously defined characteristics. Thus, total apoptotic cell counts
included cells showing the early apoptotic changes (cytoplasmic
condensation and perinuclear margination of aggregated chromatin) (Fig.
2F and 3B) through to the later stages of membrane-bound cell fragments containing uniformly dense masses of nuclear chromatin (apoptotic bodies) (Fig. 2F and 3B to D).
|
Indigenous Enterobacteriaceae have no influence on
the incidence of apoptosis.
The presence of indigenous
Enterobacteriaceae in the rabbit intestine (four of eight
rabbits within group 0) had no influence on apoptosis levels in the
ileum or ileal PP. Apoptotic indices evaluated by TUNEL or H&E staining
were similar to those found in tissues from rabbits that were culture
free of Enterobacteriaceae (Table
4). Likewise, Ac-DEVD-AMC cleavage
activities in tissues with and without Enterobacteriaceae
had similar levels in the ileum (medians were 2,209 [range, 2,027 to
2,455] and 2,289 [range, 2,094 to 2,486], respectively) and in ileal
PP (medians were 1,276 [range, 1,100 to 1,437] and 1,104 [range, 866 to 2,194], respectively). The values did not differ significantly from
each other.
|
Decrease in apoptosis in the ileum and ileal PP after infection with REPEC O103 evaluated by TUNEL staining. For apoptotic assessment, rabbits were grouped according to disease severity after infection with REPEC O103 strains. Group 0 (n = 8) contained control rabbits or animals that did not show disease symptoms. Group 1 (n = 3) showed mild symptoms (soft stool pellets with up to 7 × 107 CFU of the inoculated pathogen/g of stool, reduced weight gain, and adherence of low numbers of bacteria to intestinal surfaces as evaluated by SEM). Group 2 (n = 3) showed moderate disease (soft to watery stools with up to 5 × 109 CFU/g, weight loss, and bacterial adherence in moderate numbers). Group 3 (n = 5) experienced severe disease (diarrhea with up to 4 × 1011 CFU/g, severe weight loss, and adherence of high numbers of the pathogen). Apoptosis was assessed at tips of ileal absorptive villi and in the ileal crypt regions, as well as at tips of PP absorptive villi, PP domed villi, and PP germinal centers (Table 3).
In tips of ileal absorptive villi, PP domed villi, and PP germinal centers, apoptotic cells progressively decreased as disease symptoms increased. When disease symptoms were severe (group 3), masses of bacteria could be seen diffusely lining the intestinal surface at ileal villus tips. They exhibited a distinct dark brown staining, probably due to increased bacterial DNA synthesis (Fig. 3E and F). At this time-point, the physiological incidence of apoptotic cells could no longer be detected. Apoptotic cells were rarely seen beneath attachment sites. Additionally, the number of apoptotic cells in the depth of the villus tips was decreased. Occasionally, apoptotic cells were seen in the intestinal lumen (consistent with the observation that apoptotic intestinal cells are often shed into the lumen) (Fig. 3F). Similarly, domed villi and germinal centers of PP had fewer apoptotic cells when disease was severe (Fig. 3G and H). In germinal centers, the apoptotic index of group 3 differed significantly from that of group 0 (P = 0.01, Mann-Whitney U test). In ileal crypts and tips of PP absorptive villi, levels of apoptosis remained more or less unchanged among the four rabbit groups.Decrease in apoptosis in the ileum and ileal PP after infection with REPEC O103 evaluated by morphologic assessment (H&E staining). Rabbits were grouped, and intestinal sites were examined for the presence of apoptotic cells as already described (Table 3). Consistent with the observations made after TUNEL staining, the number of apoptotic cells in the ileum and ileal PP progressively decreased as disease symptoms increased. In ileal villi, the apoptotic index of group 3 differed significantly from that of group 0 (P = 0.04, Mann-Whitney U test). In PP, both domes and germinal centers showed decreased apoptosis, reaching borderline significance in group 3 (domes, P = 0.06; germinal centers, P = 0.06). Levels of apoptosis in ileal crypts and PP villus tips remained constant.
Decrease in apoptotic activity in the ileum after infection with
REPEC O103 evaluated with the caspase 3 assay.
To measure
intestinal caspase 3 activation, whole lysates from rabbit ileum and
ileal PP (without differentiation among absorptive villi, crypts, domed
villi, or germinal centers) were incubated with the caspase 3 fluorescent substrate Ac-DEVD-AMC and fluorescence excitation of AMC
was measured. To compare cleavage activities among rabbit tissues,
animals were grouped based on disease symptoms as described above.
Distinct caspase 3 activity was evident in ileal tissue samples from
both uninfected control rabbits and animals that did not respond or
only slightly responded to REPEC O103 infection (Fig.
4). When disease symptoms were moderate
or severe (groups 2 and 3), levels of activated caspase 3 were
significantly decreased (P = 0.01 and 0.003, respectively; Mann-Whitney U test). Apoptotic activities in PP were, in
general, lower than in ileal tissues and did not significantly differ
within the four animal groups.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, we demonstrated that apoptosis physiologically occurs in the rabbit ileum. When REPEC O103 disease was fully established and animals had heavy diarrhea, apoptosis was significantly decreased in the rabbit ileum and ileal PP. Tips of ileal absorptive villi and germinal centers of PP were the sites of most apparent changes in apoptotic activity.
It is known that apoptosis maintains a continuous 3- to 6-day cell turnover in the small intestines of humans and rats, where the Fas ligand and receptor are coexpressed (12, 17). The number of apoptotic cells increases from ileal crypts to ileal villus tips with the formation of an apoptotic cuff before enterocytes are shed into the lumen (16, 42, 43; S. F. Moss and P. R. Holt, Letter, Gastroenterology 111:567-568, 1996). In our study, we demonstrated that the rabbit ileum shows similar features of physiological apoptosis, with apoptotic cells sparse in the ileal crypt region but increasingly scattered toward the villus tip. In addition, high levels of caspase 3 activity in tissues obtained from control rabbits confirm that the ileum is a site of physiological cell turnover. In particular, we noticed a high incidence of apoptosis in germinal centers of PP. This observation is attributable to germinal centers harboring large numbers of activated immune cells that contain granzyme B, which activates caspase 3. Interestingly, we also found that the presence of indigenous nonadherent Enterobacteriaceae had no apparent influence on physiological levels of apoptosis. Apoptotic indices were equal in animals with or without cultivatable Enterobacteriaceae. This may indicate that the regulatory machinery for programmed cell death is not regulated by the indigenous ileal flora. As the number of control rabbits colonized by Enterobacteriaceae was relatively small (n = 4), further studies using a larger number of animals are required to determine if indigenous nonadherent Enterobacteriaceae affect the physiological levels of apoptosis.
The various REPEC O103 strains that were used for the experimental infection are considered highly pathogenic. They were isolated from Spanish and Belgian rabbits experiencing severe diarrhea (1, 3). Our in vitro studies showed that all of the strains adhered well to cultured cells and triggered actin accumulation and tyrosine phosphorylation, features that are critical for EPEC disease. We believe that the various isolates are almost identical in pathogenicity. We therefore grouped animals only according to disease symptoms that occurred after experimental infection, regardless of the strain that was used to infect the animals.
Invasive enteropathogens (such as Shigella,
Salmonella, and enteroinvasive E. coli species)
trigger enhanced expression of proinflammatory genes in intestinal
epithelial cells, which subsequently causes a massive increase in the
incidence of apoptotic cells in the epithelium and PP lymphoid
follicles (22, 46). Similarly, E. coli strains
such as Shiga toxin-producing EHEC O157:H7 and verotoxin-producing AEEC
O5:H
promote cytokine expression, followed by increased apoptosis
(20, 41). These infections that result in activation and
proliferation of immune cells are usually accompanied by an enhanced
release of granzyme B, resulting in the increase in apoptosis
(44). Noninvasive and non-toxin-producing EPEC, EHEC, RDEC-1, and C. rodentium, however, are believed
to decrease cytokine release, which might decrease levels of apoptosis
(26). In addition, EPEC activates intracellular pathways
that are believed to promote slower host cell killing (7, 36,
39). In this study, we observed that the incidence of apoptosis
was not increased after infection with REPEC O103. Even though severe
REPEC O103 infection is characterized by increased inflammation with a
massive influx of inflammatory cells into the ileal villi, apoptosis
was decreased in the ileum (as shown by a caspase 3 assay),
particularly at the tips of ileal absorptive villi (as determined by
H&E staining) and in germinal centers of PP (as shown by TUNEL
staining). It is tempting to interpret the decrease in the number of
apoptotic cells as a decrease in the rate of apoptosis, suggesting that REPEC O103 may, in fact, decrease apoptosis. However, the decrease in
the incidence of apoptotic cells may also be attributable to the influx
of lymphocytes and macrophages into the immune compartment and
therefore the relative increase in their numbers there. In this
instance, the rate of apoptosis may remain constant but the rate of
clearance of apoptotic debris by macrophages may be increased. This may
well be the case, as apoptotic cells undergo surface changes to
ensure rapid phagocytosis by macrophages. Investigations into this
matter, however, are beyond the scope of this study.
As shown in Table 3, apoptotic indices did not differ significantly among groups 0, 1, and 2. Eventually, values even increased in groups 1 and 2. Only when disease was severe (group 3 rabbits) did the decrease become significant. At this time, tissue morphology and cell composition had dramatically changed. It may be the case that the rabbit host initially attempted to clear the infection. Apoptosis may have been initially increased. Simultaneously or later on, the host may have tried to discard the attached pathogen and to restore intestinal cell integrity by shedding damaged epithelial cells, together with apoptotic cells, into the lumen (Fig. 3F). This may explain the observed fluctuations in the incidence of apoptosis in rabbits that were not severely diseased yet. It may reflect an immune response to an intestinal infection in general. Only when REPEC O103 disease was fully established was the decrease in apoptosis attributable to the pathogen. Whatever the case, this is an alternative interpretation. Yet, it was striking that intestinal segments harbored fewer apoptotic cells where masses of bacteria were attached (Fig. 3F). In summary, it seems obvious that REPEC O103 does not promote apoptosis compared to other enteropathogens such as Salmonella and Shigella species. REPEC O103, and possibly EPEC, may have evolved survival strategies to escape host cell defenses. Alternatively, as these pathogens remain attached to host cells for the duration of the infection, pathogenic potential may be enhanced by prolonging the life of the host cell. Studies with a larger number of animals may help to consolidate our findings and to precisely determine initial apoptotic fluctuations and events that occur later on, when the disease is established.
We demonstrated that apoptotic activities were significantly diminished in germinal centers of ileal PP when tissues were assessed by the TUNEL assay. However, apoptotic activities did not differ significantly within the four animal groups when PP were assessed by the caspase 3 assay. As whole lysates from ileal PP had to be processed for this assay, evaluation of single compartments was not possible, in contrast to the TUNEL assay, where light microscopic assessment allows differentiation of various fields. Thus, with the caspase 3 assay, apoptotic changes in PP germinal centers alone may not be sufficient to demonstrate deviations in apoptotic levels of the entire PP.
Caspase 3 plays a key role in the regulation of apoptosis. Inhibition of caspase 3, as observed in the ileum, prevents cell death by apoptosis. It has yet to be determined whether virulence proteins secreted by REPEC O103 directly inhibit caspase 3 activities. The pathogen may also inhibit apoptosis by altering the expression of Fas or FasL or producing analogues that bind to Fas but do not activate the apoptotic signal transduction pathways. It is also possible that the pedestals themselves influence the occurrence of apoptosis.
Collectively, these findings show that REPEC O103, in contrast to most other enteropathogens, does not promote apoptosis. In contrast, REPEC O103 seems to decrease apoptosis in the ileum and in germinal centers of ileal PP. If this is the case, REPEC O103 may have evolved strategies to slow down physiological cell turnover and thus to extend the time of its own attachment and to delay rapid clearance of the infection. EPEC strains thus may have evolved this strategy to counteract host cell defense mechanisms. Elucidation of the mechanisms by which these pathogens inhibit apoptosis may hold therapeutic potential for diseases caused by enhanced apoptosis (e.g., autoimmune disorders).
| |
ACKNOWLEDGMENTS |
|---|
We thank Jorge Blanco, Johan E. Peeters, Phillip Tarr, and Michael Davis for sending the rabbit EPEC and EHEC strains. We thank Ronald H. Silverman, Cornell University, Ithaca, N.Y., for help with the statistical analysis and Julie Chow for technical assistance with the histology studies.
This work was supported by a Howard Hughes International Research Scholar Award and an operating grant to B.B.F. from the Medical Research Council of Canada (MRC). B.B.F. is an MRC Scientist.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Biotechnology Laboratory, University of British Columbia, #237-6174 University Blvd., Vancouver, B.C. V6T 1Z3, Canada. Phone: (604) 822-2210. Fax: (604) 822-9830. E-mail: bfinlay{at}interchange.ubc.ca.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abe, A.,
U. Heczko,
R. G. Hegele, and B. B. Finlay.
1998.
Two enteropathogenic Escherichia coli type III secreted proteins, EspA and EspB, are virulence factors.
J. Exp. Med.
188:1907-1916 |
| 2. |
Berg, R. D.
1980.
Inhibition of Escherichia coli translocation from the gastrointestinal tract by normal cecal flora in gnotobiotic or antibiotic-decontaminated mice.
Infect. Immun.
29:1073-1081 |
| 3. | Blanco, J. E., M. Blanco, J. Blanco, A. Mora, L. Balaguer, M. Mourino, A. Juarez, and W. H. Jansen. 1996. O serogroups, biotypes, and eae genes in Escherichia coli strains isolated from diarrheic and healthy rabbits. J. Clin. Microbiol. 34:3101-3107[Abstract]. |
| 4. |
Camguilhem, R., and A. Milon.
1989.
Biotypes and O serogroups of Escherichia coli involved in intestinal infections of weaned rabbits: clues to diagnosis of pathogenic strains.
J. Clin. Microbiol.
27:743-747 |
| 5. |
Cheney, C. P.,
P. A. Schad,
S. B. Formal, and E. C. Boedeker.
1980.
Species specificity of in vitro Escherichia coli adherence to host intestinal cell membranes and its correlation with in vivo colonization and infectivity.
Infect. Immun.
28:1019-1027 |
| 6. |
Crane, J. K.,
S. Majumdar, and D. F. Pickhardt, 3rd.
1999.
Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.
Infect. Immun.
67:2575-2584 |
| 7. | Crane, J. K., and J. S. Oh. 1997. Activation of host cell protein kinase C by enteropathogenic Escherichia coli. Infect. Immun. 65:3277-3285[Abstract]. |
| 8. |
Donnenberg, M. S.,
S. B. Calderwood,
A. Donohue-Rolfe,
G. T. Keusch, and J. B. Kaper.
1990.
Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells.
Infect. Immun.
58:1565-1571 |
| 9. | Donnenberg, M. S., J. B. Kaper, and B. B. Finlay. 1997. Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol. 5:109-114[CrossRef][Medline]. |
| 10. | Fagundes-Neto, U., E. Freymuller, L. Gandolfi Schimitz, and I. Scaletsky. 1996. Nutritional impact and ultrastructural intestinal alterations in severe infections due to enteropathogenic Escherichia coli strains in infants. J. Am. Coll. Nutr. 15:180-185[Abstract]. |
| 11. |
Giron, J. A.,
A. S. Ho, and G. K. Schoolnik.
1991.
An inducible bundle-forming pilus of enteropathogenic Escherichia coli.
Science
254:710-713 |
| 12. | Granville, D. J., C. M. Carthy, D. W. Hunt, and B. M. McManus. 1998. Apoptosis: molecular aspects of cell death and disease. Lab. Investig. 78:893-913[Medline]. |
| 13. | Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann. Intern. Med. 109:705-712. |
| 14. | Heczko, U., A. Abe, and B. B. Finlay. 2000. In vivo interactions of rabbit enteropathogenic Escherichia coli O103 with its host: an electron microscopic and histopathologic study. Microbes Infect. 2:5-16[CrossRef][Medline]. |
| 15. | Heczko, U., A. Abe, and B. B. Finlay. 2000. Segmented filamentous bacteria prevent colonization of enteropathogenic Escherichia coli O103 in rabbits. J. Infect. Dis. 181:1027-1033[CrossRef][Medline]. |
| 16. | Iwanaga, T., O. Hoshi, H. Han, H. Takahashi-Iwanaga, Y. Uchiyama, and T. Fujita. 1994. Lamina propria macrophages involved in cell death (apoptosis) of enterocytes in the small intestine of rats. Arch Histol. Cytol. 57:267-276[Medline]. |
| 17. |
Jones, B. A., and G. J. Gores.
1997.
Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine.
Am. J. Physiol.
273:G1174-G1188 |
| 18. |
Jones, N. L.,
A. S. Day,
H. A. Jennings, and P. M. Sherman.
1999.
Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression.
Infect. Immun.
67:4237-4242 |
| 19. | Kaper, J. B., T. K. McDaniel, K. G. Jarvis, and O. Gomez-Duarte. 1997. Genetics of virulence of enteropathogenic E. coli. Adv. Exp. Med. Biol. 412:279-287[Medline]. |
| 20. |
Karpman, D.,
A. Hakansson,
M. T. Perez,
C. Isaksson,
E. Carlemalm,
A. Caprioli, and C. Svanborg.
1998.
Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.
Infect. Immun.
66:636-644 |
| 21. | Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520[CrossRef][Medline]. |
| 22. | Kim, J. M., L. Eckmann, T. C. Savidge, D. C. Lowe, T. Witthoft, and M. F. Kagnoff. 1998. Apoptosis of human intestinal epithelial cells after bacterial invasion. J. Clin. Investig. 102:1815-1823[Medline]. |
| 23. | Kiyokawa, N., T. Taguchi, T. Mori, H. Uchida, N. Sato, T. Takeda, and J. Fujimoto. 1998. Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J. Infect. Dis. 178:178-184[Medline]. |
| 24. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 25. | Levine, M. M., E. J. Bergquist, D. R. Nalin, D. H. Waterman, R. B. Hornick, C. R. Young, and S. Sotman. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet i:1119-1122. |
| 26. |
Malstrom, C., and S. James.
1998.
Inhibition of murine splenic and mucosal lymphocyte function by enteric bacterial products.
Infect. Immun.
66:3120-3127 |
| 27. |
Mills, S. D.,
A. Boland,
M. P. Sory,
P. van der Smissen,
C. Kerbourch,
B. B. Finlay, and G. R. Cornelis.
1997.
Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein.
Proc. Natl. Acad. Sci. USA
94:12638-12643 |
| 28. |
Milon, A.,
J. Esslinger, and R. Camguilhem.
1990.
Adhesion of Escherichia coli strains isolated from diarrheic weaned rabbits to intestinal villi and HeLa cells.
Infect. Immun.
58:2690-2695 |
| 29. |
Monack, D. M.,
J. Mecsas,
D. Bouley, and S. Falkow.
1998.
Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice.
J. Exp. Med.
188:2127-2137 |
| 30. | Neter, E. 1965. Enteritis due to enteropathogenic Escherichia coli. Am. J. Dig. Dis. 10:883-886[CrossRef][Medline]. |
| 31. |
Peeters, J. E.,
R. Geeroms, and F. Orskov.
1988.
Biotype, serotype, and pathogenicity of attaching and effacing enteropathogenic Escherichia coli strains isolated from diarrheic commercial rabbits.
Infect. Immun.
56:1442-1448 |
| 32. |
Peeters, J. E.,
P. Pohl,
L. Okerman, and L. A. Devriese.
1984.
Pathogenic properties of Escherichia coli strains isolated from diarrheic commercial rabbits.
J. Clin. Microbiol.
20:34-39 |
| 33. | Pillien, F., C. Chalareng, M. Boury, C. Tasca, J. de Rycke, and A. Milon. 1996. Role of adhesive factor/rabbit 2 in experimental enteropathogenic Escherichia coli O103 diarrhea of weaned rabbit. Vet. Microbiol. 50:105-115[CrossRef][Medline]. |
| 34. |
Richter-Dahlfors, A.,
A. M. J. Buchan, and B. B. Finlay.
1997.
Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo.
J. Exp. Med.
186:569-580 |
| 35. | Roach, S., and G. W. Tannock. 1979. Indigenous bacteria influence the number of Salmonella typhimurium in the ileum of gnotobiotic mice. Can. J. Microbiol. 25:1352-1358[Medline]. |
| 36. | Rosenshine, I., M. S. Donnenberg, J. B. Kaper, and B. B. Finlay. 1992. Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. EMBO J. 11:3551-3560[Medline]. |
| 37. | Rosenshine, I., S. Ruschkowski, M. Stein, D. J. Reinscheid, S. D. Mills, and B. B. Finlay. 1996. A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation. EMBO J. 15:2613-2624[Medline]. |
| 38. | Rothbaum, R. J., J. C. Partin, K. Saalfield, and A. J. McAdams. 1983. An ultrastructural study of enteropathogenic Escherichia coli infection in human infants. Ultrastruct. Pathol. 4:291-304[Medline]. |
| 39. | Savkovic, S. D., A. Koutsouris, and G. Hecht. 1997. Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am. J. Physiol. 273:C1160-7. |
| 40. |
Tarr, P. I.,
L. S. Fouser,
A. E. Stapleton,
R. A. Wilson,
H. H. Kim,
J. C. Vary, Jr., and C. R. Clausen.
1996.
Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2.
N. Engl. J. Med.
335:635-638 |
| 41. | Wada, Y., K. Mori, and T. Iwanaga. 1997. Apoptosis of enterocytes induced by inoculation of a strain of attaching and effacing Escherichia coli and verotoxin. J. Vet. Med. Sci. 59:815-818[CrossRef][Medline]. |
| 42. | Watson, A. J. 1997. The role of apoptosis in intestinal disease. J. Gastroenterol. 32:414-423[Medline]. |
| 43. | Westcarr, S., P. Farshori, J. Wyche, and W. A. Anderson. 1999. Apoptosis and differentiation in the crypt-villus unit of the rat small intestine. J. Submicrosc. Cytol. Pathol. 31:15-30[Medline]. |
| 44. |
Zapata, J. M.,
R. Takahashi,
G. S. Salvesen, and J. C. Reed.
1998.
Granzyme release and caspase activation in activated human T-lymphocytes.
J Biol. Chem.
273:6916-6920 |
| 45. | Zychlinsky, A., and P. J. Sansonetti. 1997. Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death? Trends Microbiol. 5:201-204[CrossRef][Medline]. |
| 46. | Zychlinsky, A., K. Thirumalai, J. Arondel, J. R. Cantey, A. O. Aliprantis, and P. J. Sansonetti. 1996. In vivo apoptosis in Shigella flexneri infections. Infect. Immun. 64:5357-5365[Abstract]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|